Sumitomo Pharma America Inc - Company Profile
Powered by
All the data and insights you need on Sumitomo Pharma America Inc in one report.
- Save hours of research time and resources with
our up-to-date Sumitomo Pharma America Inc Strategy Report
- Understand Sumitomo Pharma America Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sumitomo Pharma America Inc (Sumitomo Pharma), formerly Sunovion Pharmaceuticals Inc, is a pharmaceutical company that discovers, develops, and commercializes therapeutic products for central nervous system and respiratory disorders and other illnesses. The company’s business agreements and synergy with its parent company are its major strengths, even as private ownership restricts ability to raise funds could be a cause for concern. The company could find ample opportunities from its strategic initiatives, growing incidence of anxiety globally, pipeline products and rising healthcare expenditure in the US. However, competition, stringent regulations and uncertain R&D outcomes could affect the company’s operational and financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer